Shandong Weigao Medical Polymer Co. (OTCMKTS:SHWGF) Short Interest Down 25.9% in September

Key Points

• Shandong Weigao Medical Polymer Co. experienced a 25.9% decrease in short interest in September, reducing from 21,362,600 shares to 15,836,200 shares as of September 15th.
• The company's stock opened at $0.76, with a fifty-two week low of $0.65 and a high of $0.76, indicating it has been relatively stable over the past year.
• Shandong Weigao is involved in the research, development, and production of various medical devices across several segments, including medical device products and orthopedic products.

Shandong Weigao Medical Polymer Co. (OTCMKTS:SHWGF - ) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totaling 15,836,200 shares, a drop of 25.9% from the August 31st total of 21,362,600 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Shandong Weigao Medical Polymer Price Performance

OTCMKTS:SHWGF opened at $0.76 on Tuesday. The firm's fifty day simple moving average is $0.76 and its 200-day simple moving average is $0.76. Shandong Weigao Medical Polymer has a fifty-two week low of $0.65 and a fifty-two week high of $0.76.

About Shandong Weigao Medical Polymer

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.